Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A

NCT05970679 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia, Dyslipidemia

Interventions

DRUG: Ezetimibe/Atorvastatin 10/5 mg
DRUG: Atorvastatin 5mg
DRUG: Ezetimibe 10mg
DRUG: Atorvastatin 10mg
DRUG: DW1125 placebo
DRUG: DW1125A placebo
DRUG: DW1125E placebo
DRUG: DW1125A-1 placebo

Sponsor

Daewon Pharmaceutical Co., Ltd.